EVFM

Evofem Biosciences, Inc.

Company with tickers: EVFM

CIK

1618835

CUSIP

30048L302

Shares Outstanding

132,530,081

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Fiscal Year Ended	Cash Spent	Shares	Avg Price	Source
2022-12-31	$18,000	—	—	10-K, filed 2024-03-27
2021-12-31	$0	—	—	10-K, filed 2023-04-27

Recent quarters

Quarter Ended	Cash Spent	Shares	Avg Price	Source
2022-12-31	$0 Δ	—	—	10-K, filed 2024-03-27
2022-09-30	$0 Δ	—	—	10-Q, filed 2023-11-14
2021-12-31	$0 Δ	—	—	10-K, filed 2023-04-27
2021-09-30	$0 Δ	—	—	10-Q, filed 2023-01-06